The relationship of telmisartan with sclerostin in the osteoporosis model induced by ovariectomy in rats

KUTLU Z., BİLEN A., ÇELİK M., MAMAN A., GÜLABOĞLU M., KUL A., ...Daha Fazla

JOURNAL OF PHARMACY AND PHARMACOLOGY, cilt.73, sa.12, ss.1693-1702, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 73 Sayı: 12
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1093/jpp/rgab123
  • Dergi Adı: JOURNAL OF PHARMACY AND PHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Aquatic Science & Fisheries Abstracts (ASFA), BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, EMBASE, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.1693-1702
  • Anahtar Kelimeler: angiotensin II receptor, osteocalcin, osteoporosis, sclerostin, tartrate-resistant acid phosphatase, BONE TURNOVER MARKERS, ANGIOTENSIN-II, SERUM SCLEROSTIN, MINERAL DENSITY, RECEPTOR, EPIDEMIOLOGY, HYPERTENSION, INHIBITION, BIOLOGY, DAMAGE
  • Atatürk Üniversitesi Adresli: Evet

Özet

Objectives Our aim is to explain the relationship between Ang II and Scl in osteoporotic (OP) rats and the contribution of Scl in the antiosteoporotic effect mechanism of angiotensin receptor blockers (ARB).